Evidence map›Paper›PMID 2148321›Full record

Trial reportJournal of clinical immunology1990

Effect of local deposition of antigen on salivary immune responses and reaccumulation of mutans streptococci.

D J Smith, M A Taubman

Abstract readClinical TrialControlled Clinical Trial
PubMed Publisher
In one paragraph

Trial report in Journal of clinical immunology, 1990. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Review
  3. Observational
  4. Review
  5. Dental caries vaccine - a possible option?Journal of clinical and diagnostic research : JCDR · 2013
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Human T-cell responses to the glucosyltransferases of Streptococcus mutans.Clinical and diagnostic laboratory immunology · 2001
    Article
  12. Oral microbial ecology and the role of salivary immunoglobulin A.Microbiology and molecular biology reviews : MMBR · 1998
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

D J SmithDepartment of Immunology, Forsyth Dental Center, Boston, Massachusetts 02115.
M A Taubman
Novant Health Forsyth Medical Center · US

Funding

CHILDHOOD VACCINES AND DENTAL CARIES IMMUNITYR37DE006153 · NIDCR · FORSYTH INSTITUTE · PI SMITH, DANIEL JAMES · 1998 to 2007
$3.9M
SYNTHETIC PEPTIDE VACCINES FOR DENTAL CARIESR01DE004733 · NIDCR · FORSYTH INSTITUTE · PI TAUBMAN, MARTIN A · 1985 to 2005
$3.0M
Passive Immunotherapy for Pediatric Mutans Streptococcal InfectionsR56DE004733 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI TAUBMAN, MARTIN A · 2007 to 2009
$2.1M
CHILDHOOD VACCINES AND DENTAL CARIES IMMUNITYR01DE006153 · NIDCR · FORSYTH INSTITUTE · PI SMITH, DANIEL J. · 1985 to 1998
–
NIDCR NIH HHS DE-04733NIDCR NIH HHS DE-06153
6 · The paper itself

Abstract

In this study glucosyltransferase (GTF) from Streptococcus sobrinus was topically administered onto the lower lips of young adults. The effect of this route of antigenic exposure on labial and parotid gland and serum antibody levels to GTF and on the reaccumulation of indigenous mutans streptococci after a dental prophylaxis was then measured. Young adults between 18 and 42 years of age were screened for levels of antibody activity to GTF in parotid and labial gland salivas and levels of mutans streptococci in their whole saliva. Prior to antigen administration, two groups were formed which had similar distributions of mutans streptococci in their whole saliva. Antigen (GTF) or placebo, each combined with aluminum phosphate (AP), was then administered to the lower lip daily for 5 days. Immediately prior to topical application of GTF or placebo to the labial salivary glands, all subjects were given a dental prophylaxis. Statistically significant differences in anti-GTF IgA antibody activity in parotid or labial salivas were not observed between the GTF-administered and the placebo groups during the 6 weeks following topical application. However, the proportions of indigenous mutans streptococci/total streptococcal flora, or total cultivable flora, were always lower in the whole salivas of the GTF, compared with the placebo group. These differences were statistically significant on days 13, 20, 34, and 41 after initial topical application. Delays in reaccumulation were significantly associated (P less than 0.025) with elevations in parotid saliva IgA antibody levels of all subjects. Seven of 10 of the subjects demonstrating this association were in the group to which GTF was topically administered.(ABSTRACT TRUNCATED AT 250 WORDS)

Indexed as

Administration, TopicalAdolescentAdultAntibodies, BacterialAntigens, BacterialGlucosyltransferasesHumansImmunoglobulin A, SecretoryLipParotid GlandSalivaSalivary GlandsStreptococcusStreptococcus mutans1,3-alpha-D-glucan synthaseAntibodies, BacterialAntigens, BacterialGlucosyltransferasesImmunoglobulin A, Secretory

Identifiers

PMID2148321
OpenAlexW2054108742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.